e-learning
resources
London 2016
Tuesday, 06.09.2016
Oligometastasis: postmodern multimodality concepts
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What are oligometastases?
Joachim Pfannschmidt (Berlin, Germany)
Source:
International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Session:
Oligometastasis: postmodern multimodality concepts
Session type:
Symposium
Number:
3473
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Joachim Pfannschmidt (Berlin, Germany). What are oligometastases?. International Congress 2016 – Oligometastasis: postmodern multimodality concepts
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Treatment options for isolated locoregional recurrences of nonsmall cell lung cancer after surgery: yes, radiation therapy too!
Source: Eur Respir J 2016; 48: 276-278
Year: 2016
Prehabilitation can turn inoperable patients with NSLC to operable ones?
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020
Genetics and evolution of primaries and oligometastases
Source: International Congress 2016 – Oligometastasis: postmodern multimodality concepts
Year: 2016
Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Palliative care or standard chemotherapy in lung cancer patients?
Source: Annual Congress 2012 - Ethics Grand Round: an interactive session
Year: 2012
Detection of operable lung cancer – a question of sheer luck?
Source: Eur Respir J 2007; 30: Suppl. 51, 563s
Year: 2007
Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC
Source: Eur Respir J 2012; 39: 1039-1042
Year: 2012
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Is there a role for radiotherapy in mediastinal tumours?
Source: Annual Congress 2013 –Mediastinal tumours excluding thymoma
Year: 2013
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Follow-up after lung cancer resection: is intensified also justified?
Source: Eur Respir J 2013; 42: 1178-1179
Year: 2013
Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept